Indication
Multicentric Castleman's disease
Multicentric Castleman's disease is a rare, life-threatening lymphoproliferative disorder that affects multiple lymph node stations and lymphoid tissues throughout the body. Read more about Multicentric Castleman's disease
4 drugs 4 manufacturers
Drugs that treat it
Common Multicentric Castleman's disease therapies.
SYLVANT (siltuximab)
SYLVANT (siltuximab)
SYLVANT (siltuximab)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMulticentric Castleman's disease is a rare, life-threatening lymphoproliferative disorder that affects multiple lymph node stations and lymphoid tissues throughout the body.
It can manifest across broad adult populations as either idiopathic or associated with human herpesvirus 8 (HHV-8), the latter frequently occurring alongside human immunodeficiency virus (HIV) co-infection.
Pathophysiologically, the disease is driven by a hyperinflammatory cytokine storm—predominantly involving interleukin-6 (IL-6)—which leads to characteristic histopathological lymphadenopathy, polyclonal hypergammaglobulinemia, and profound systemic manifestations including fevers, night sweats, cytopenias, hepatosplenomegaly, and progressive multi-organ dysfunction.
- nih.gov
Multicentric Castleman's disease is a rare, life-threatening lymphoproliferative disorder that affects multiple lymph node stations and lymphoid tissues throughout the body
- nih.gov
Multicentric Castleman's disease is a rare, life-threatening lymphoproliferative disorder that affects multiple lymph node stations and lymphoid tissues throughout the body
- mayoclinic.org
It can manifest across broad adult populations as either idiopathic or associated with human herpesvirus 8 (HHV-8), the latter frequently occurring alongside human immunodeficiency virus (HIV) co-infection
- cancer.gov
It can manifest across broad adult populations as either idiopathic or associated with human herpesvirus 8 (HHV-8), the latter frequently occurring alongside human immunodeficiency virus (HIV) co-infection
- disease-ontology.org
Pathophysiologically, the disease is driven by a hyperinflammatory cytokine storm—predominantly involving interleukin-6 (IL-6)—which leads to characteristic histopathological lymphadenopathy, polyclonal hypergammaglobulinemia, and profound systemic manifestations including fevers, night sweats, cytopenias, hepatosplenomegaly, and progressive multi-organ dysfunction
- nih.gov
Pathophysiologically, the disease is driven by a hyperinflammatory cytokine storm—predominantly involving interleukin-6 (IL-6)—which leads to characteristic histopathological lymphadenopathy, polyclonal hypergammaglobulinemia, and profound systemic manifestations including fevers, night sweats, cytopenias, hepatosplenomegaly, and progressive multi-organ dysfunction
Personalize your experience
Follow Multicentric Castleman's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.